BIOCELL

Scope & Guideline

Pioneering Discoveries in Molecular Biology

Introduction

Welcome to the BIOCELL information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of BIOCELL, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0327-9545
PublisherTECH SCIENCE PRESS
Support Open AccessNo
CountryArgentina
TypeJournal
Convergefrom 1995 to 2013, from 2015 to 2024
AbbreviationBIOCELL / Biocell
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052

Aims and Scopes

BIOCELL is a journal dedicated to the exploration of cellular and molecular biology, emphasizing the interplay between biological systems and their microenvironments. The journal aims to publish high-quality research that elucidates mechanisms underlying cellular functions, disease processes, and therapeutic interventions.
  1. Cellular and Molecular Mechanisms:
    Research articles focusing on the intricate cellular pathways and molecular mechanisms that govern various biological processes, including cell proliferation, differentiation, apoptosis, and autophagy.
  2. Stem Cell Biology and Regenerative Medicine:
    A significant focus on the properties, applications, and therapeutic potentials of stem cells, including their roles in tissue engineering, regeneration, and treatment of various diseases.
  3. Cancer Biology and Therapeutics:
    Investigations into the molecular and cellular underpinnings of cancer, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic approaches.
  4. Immunology and Host-Pathogen Interactions:
    Studies that explore the immune response to pathogens, the mechanisms of immune evasion by cancer cells, and the development of immunotherapies.
  5. Bioinformatics and Systems Biology:
    Utilization of computational methods and bioinformatics tools to analyze large datasets, identify biomarkers, and understand complex biological interactions.
  6. Nanotechnology and Biomaterials:
    Research highlighting the application of nanomaterials and biomaterials in biological systems, particularly in drug delivery, diagnostics, and tissue engineering.
BIOCELL has been progressively embracing emerging trends in research, reflecting the dynamic nature of the fields of cellular and molecular biology. The following themes have gained significant traction in recent publications.
  1. Single-Cell Sequencing and Transcriptomics:
    There is a marked increase in studies utilizing single-cell sequencing technologies to explore cellular heterogeneity and gene expression profiles, particularly in cancer and immune responses.
  2. Microbiome and Host Interactions:
    Research exploring the gut microbiome's influence on health and disease, including its interactions with host cells and implications for personalized medicine, has emerged as a key area of interest.
  3. Advancements in Nanotechnology:
    The application of nanotechnology in drug delivery systems, diagnostics, and therapeutic interventions is increasingly prominent, reflecting the journal's commitment to cutting-edge research.
  4. Cancer Immunotherapy:
    A growing body of work focuses on cancer immunotherapy, including the mechanisms of immune evasion and the development of novel immunotherapeutic strategies.
  5. Epigenetic Modifications in Health and Disease:
    There is an increasing emphasis on studies investigating the role of epigenetic changes in various diseases, including cancer and metabolic disorders, highlighting their potential as therapeutic targets.
  6. Biomaterials for Tissue Engineering:
    Research on innovative biomaterials for tissue engineering applications is gaining momentum, particularly those that enhance cellular interactions and promote regeneration.

Declining or Waning

While BIOCELL has consistently focused on several core areas, certain themes appear to be waning in prominence as the journal evolves to address emerging scientific challenges and innovations.
  1. Traditional Pharmacological Studies:
    There seems to be a decline in publications centered on classical pharmacological approaches, as the journal shifts towards more innovative and integrative methodologies.
  2. In vitro Models with Limited Relevance:
    Research utilizing simplistic in vitro models that do not adequately mimic the complexity of in vivo systems appears to be decreasing, as the field moves towards more sophisticated models, including organ-on-a-chip technologies.
  3. Basic Plant Biology Studies:
    While still relevant, there is a noticeable reduction in the number of studies solely focused on fundamental plant biology, as the journal pivots towards translational research and applications in human health.
  4. Non-targeted Metabolomics:
    The focus on non-targeted metabolomics studies has diminished, likely due to the growing emphasis on targeted approaches that yield more actionable insights in therapeutic contexts.
  5. Animal Studies with Limited Clinical Relevance:
    Research involving animal models that do not translate well to human conditions is less frequently published, reflecting a trend towards studies that emphasize translational potential.

Similar Journals

CELL DEATH AND DIFFERENTIATION

Exploring the Frontiers of Cellular Dynamics
Publisher: SPRINGERNATUREISSN: 1350-9047Frequency: 12 issues/year

CELL DEATH AND DIFFERENTIATION, published by SpringerNature, is a leading peer-reviewed journal that has been at the forefront of advancing knowledge in the fields of cell biology and molecular biology since its inception in 1994. With an impressive impact factor and ranking in the Q1 quartile for both categories as of 2023, it is recognized as an essential resource for researchers and professionals dedicated to understanding the intricate processes of cellular death and differentiation. The journal publishes high-quality original research articles, reviews, and commentaries, fostering an interdisciplinary dialogue among scientists exploring the molecular mechanisms that underpin these fundamental biological processes. With its commitment to excellence, CEL DEATH AND DIFFERENTIATION bridges gaps in knowledge and stimulates innovation within the scientific community. To access cutting-edge research from this prestigious journal, you may visit their website for subscription options and explore a wealth of knowledge that is crucial for advancing the frontiers of biological research.

BIOSCIENCE REPORTS

Connecting Researchers with Groundbreaking Findings
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

International Journal of Molecular and Cellular Medicine

Elevating Understanding in Molecular and Cellular Medicine
Publisher: CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTERISSN: 2251-9637Frequency: 4 issues/year

International Journal of Molecular and Cellular Medicine, published by the CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER in Iran, is a leading platform dedicated to advancing research in various domains of molecular and cellular sciences. With an ISSN of 2251-9637 and E-ISSN 2251-9645, this journal features a rigorous peer-review process that ensures the publication of high-quality, impactful research. Spanning from 2016 to 2024, it is categorized in the third quartile (Q3) in Biochemistry, Cell Biology, Genetics, and Molecular Biology, and second quartile (Q2) in Biotechnology, underlining its significance in the scientific community. Although currently non-open access, it maintains credible visibility through Scopus rankings, reflecting its importance in fields such as Biochemistry, Molecular Medicine, and Genetics, where it holds respectable ranks and percentiles. This journal aims to foster collaboration and knowledge dissemination among researchers, professionals, and students in the pursuit of enhancing understanding and innovation in molecular and cellular medicine.

Cell Stem Cell

Advancing the Frontiers of Stem Cell Research
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Cell Discovery

Pioneering Discoveries in Molecular and Genetic Sciences
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

Cellular and Molecular Bioengineering

Innovating at the Intersection of Biology and Technology
Publisher: SPRINGERISSN: 1865-5025Frequency: 4 issues/year

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Unlocking the Secrets of Life at the Molecular Level
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

Life Science Alliance

Advancing the Frontiers of Life Sciences.
Publisher: LIFE SCIENCE ALLIANCE LLCISSN: Frequency: 6 issues/year

Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.

CELLULAR AND MOLECULAR BIOLOGY

Unveiling the Secrets of Biochemical Processes
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

Genes & Diseases

Bridging the gap between genetics and clinical applications.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.